中国药师
中國藥師
중국약사
CHINA PHARMACIST
2015年
6期
939-942,943
,共5页
郭春%陈民辉%李忠红%王勇
郭春%陳民輝%李忠紅%王勇
곽춘%진민휘%리충홍%왕용
卡络磺钠注射剂%评价性抽验%质量评价
卡絡磺鈉註射劑%評價性抽驗%質量評價
잡락광납주사제%평개성추험%질량평개
Carbazochrome sodium sulfonate Injection%Evaluation sampling%Quality evaluation
目的::对国内不同厂家生产的卡络磺钠注射剂的质量进行对比研究,分析存在的问题,为提高临床用药安全提供参考依据。方法:采用法定检验方法结合探索性研究进行样品检验,统计分析检验结果,进行质量风险分析。结果:按照现行标准检验89批样品,合格率为97.8%,2批不合格样品为卡络磺钠氯化钠注射液,不合格项目均为不溶性微粒。注射用卡络磺钠的质量风险较小,卡络磺钠氯化钠注射液的安全性有待进一步研究。结论:目前卡络磺钠注射剂的产品质量基本能符合现行标准要求,探索性研究提示现行标准存在不足,建议完善有关物质检查方法,合理制定降解杂质以及其他杂质的限度,并应对卡络磺钠氯化钠注射液的安全性进行深入研究。
目的::對國內不同廠傢生產的卡絡磺鈉註射劑的質量進行對比研究,分析存在的問題,為提高臨床用藥安全提供參攷依據。方法:採用法定檢驗方法結閤探索性研究進行樣品檢驗,統計分析檢驗結果,進行質量風險分析。結果:按照現行標準檢驗89批樣品,閤格率為97.8%,2批不閤格樣品為卡絡磺鈉氯化鈉註射液,不閤格項目均為不溶性微粒。註射用卡絡磺鈉的質量風險較小,卡絡磺鈉氯化鈉註射液的安全性有待進一步研究。結論:目前卡絡磺鈉註射劑的產品質量基本能符閤現行標準要求,探索性研究提示現行標準存在不足,建議完善有關物質檢查方法,閤理製定降解雜質以及其他雜質的限度,併應對卡絡磺鈉氯化鈉註射液的安全性進行深入研究。
목적::대국내불동엄가생산적잡락광납주사제적질량진행대비연구,분석존재적문제,위제고림상용약안전제공삼고의거。방법:채용법정검험방법결합탐색성연구진행양품검험,통계분석검험결과,진행질량풍험분석。결과:안조현행표준검험89비양품,합격솔위97.8%,2비불합격양품위잡락광납록화납주사액,불합격항목균위불용성미립。주사용잡락광납적질량풍험교소,잡락광납록화납주사액적안전성유대진일보연구。결론:목전잡락광납주사제적산품질량기본능부합현행표준요구,탐색성연구제시현행표준존재불족,건의완선유관물질검사방법,합리제정강해잡질이급기타잡질적한도,병응대잡락광납록화납주사액적안전성진행심입연구。
Objective:To evaluate the quality of carbazochrome sodium sulfonate Injection from different manufacturers, analyze the existing problems and provide the reference for the improvement of clinical medication safety. Methods:Statutory testing methods and the exploratory research methods were used to examine the samples, and the quality status of carbazochrome sodium sulfonate Injec-tion was evaluated according to the results. Results:Totally 89 batches of the samples were tested by the current standard. The quali-fied rate was 97. 8%, and the two batches of unqualified samples were carbazochrome sodium sulfonate and sodium chloride Injection with unqualified insoluble particles. Overall, the quality risk of carbazochrome sodium sulfonate for injection was low, and the safety of carbazochrome sodium sulfonate and sodium chloride Injection needed further research. Conclusion:The quality of carbazochrome so-dium sulfonate Injection basically meets the current standard, and the exploratory research suggests that the current standard is imper-fect. It is urgent to improve the related substance detection in the standard and determine the reasonable limits for the degradation im-purities and the other impurities. The clinical medication safety of carbazochrome sodium sulfonate and sodium chloride Injection needs further research.